NASDAQ:MDCO - The Medicines Stock Price, Forecast & News

The Medicines trades on the NASDAQ under the ticker symbol "MDCO."

The Medicines Company (NASDAQ:MDCO) released its earnings results on Wednesday, October, 30th. The company reported ($0.92) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.80) by $0.12. During the same quarter in the previous year, the company posted ($0.70) earnings per share. View The Medicines' Earnings History.

The Medicines is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for The Medicines.

14 equities research analysts have issued 1 year price targets for The Medicines' stock. Their forecasts range from $49.00 to $145.00. On average, they expect The Medicines' stock price to reach $75.08 in the next twelve months. This suggests that the stock has a possible downside of 11.6%. View Analyst Price Targets for The Medicines.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Medicines in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for The Medicines.

Media headlines about MDCO stock have trended neutral this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. The Medicines earned a daily sentiment score of 0.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for The Medicines.

Some companies that are related to The Medicines include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT).

Based on aggregate information from My MarketBeat watchlists, some companies that other The Medicines investors own include NVIDIA (NVDA), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), salesforce.com (CRM), AT&T (T), Bank of America (BAC), Ionis Pharmaceuticals (IONS) and Cisco Systems (CSCO).

The Medicines' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Farallon Capital Management LLC (4.16%), Maverick Capital Ltd. (2.73%), Magnetar Financial LLC (2.37%), CNH Partners LLC (1.92%), Iridian Asset Management LLC CT (1.82%) and Westfield Capital Management Co. LP (1.72%). Company insiders that own The Medicines stock include Alexander J Denner, Armin M Kessler, Christopher T Cox, Clive Meanwell, Mark Timney, Melvin K Spigelman, Stephen M Rodin and William Crouse. View Institutional Ownership Trends for The Medicines.

MDCO stock was sold by a variety of institutional investors in the last quarter, including Graham Capital Management L.P., Mackay Shields LLC, Westfield Capital Management Co. LP, Maverick Capital Ltd., Iridian Asset Management LLC CT, Marshall Wace LLP, Panagora Asset Management Inc. and Renaissance Technologies LLC. View Insider Buying and Selling for The Medicines.

MDCO stock was purchased by a variety of institutional investors in the last quarter, including Farallon Capital Management LLC, Magnetar Financial LLC, CNH Partners LLC, IndexIQ Advisors LLC, ARP Americas LP, Beryl Capital Management LLC, Gabelli Funds LLC and Marshall Wace North America L.P.. Company insiders that have bought The Medicines stock in the last two years include Alexander J Denner, Christopher T Cox and Mark Timney. View Insider Buying and Selling for The Medicines.

Shares of MDCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDCO stock can currently be purchased for approximately $84.90.

The Medicines has a market capitalization of $6.77 billion and generates $6.14 million in revenue each year. The company earns $-123,160,000.00 in net income (profit) each year or ($2.91) on an earnings per share basis. The Medicines employs 62 workers across the globe.View Additional Information About The Medicines.

The official website for The Medicines is http://www.themedicinescompany.com/.

The Medicines' mailing address is 8 SYLVAN WAY, PARSIPPANY NJ, 07054. The company can be reached via phone at 973-290-6000 or via email at [email protected]